Study of Visceral Leishmaniasis Cases and Treatments in Emilia-Romagna Observing Patient Characteristics and Therapy Results from 2020 to 2025

What this Trial Is About

Researchers are conducting an observational study to understand the spread and characteristics of visceral Leishmaniasis LV in the Emilia-Romagna region, where cases have increased since 2012. This disease is caused by Leishmania parasites and affects various animals and humans, with significant health impacts worldwide. The study aims to provide scientific data to support guidelines for diagnosis and treatment, reduce delays in diagnosis, and improve therapy outcomes. It also seeks to explore new ways to control the disease and reduce its transmission. The study is retrospective and prospective, gathering data from patients diagnosed with visceral Leishmaniasis between March 2020 and February 2025. It involves observing the epidemiology, socio-demographic and clinical features of patients, and evaluating the accuracy of diagnostic methods. The study also monitors how well therapies are tolerated and assesses the treatment results over the same period. Participants diagnosed with LV will provide information through medical records and clinical data. Researchers will evaluate diagnostic test accuracy, treatment tolerability, and therapeutic outcomes. The study collects this information to better understand the diseases behavior in the region and improve management strategies. Participation involves no direct intervention, and data collection spans five years, ending in December 2025.

Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)